Canaccord Genuity reissued their buy rating on shares of Ideagen (LON:IDEA) in a research note issued to investors on Wednesday, Digital Look reports. Canaccord Genuity currently has a GBX 180 ($2.35) target price on the stock.
Separately, FinnCap restated a corporate rating on shares of Ideagen in a research note on Friday, October 11th.
Ideagen stock remained flat at $GBX 152 ($1.99) during midday trading on Wednesday. The company had a trading volume of 119,495 shares, compared to its average volume of 93,247. The firm has a fifty day moving average price of GBX 148.79 and a 200-day moving average price of GBX 145.32. The stock has a market capitalization of $343.76 million and a PE ratio of 253.33. Ideagen has a 52-week low of GBX 41 ($0.54) and a 52-week high of GBX 160.45 ($2.10). The company has a debt-to-equity ratio of 10.18, a current ratio of 0.69 and a quick ratio of 0.61.
In other news, insider David Hornsby sold 260,000 shares of the company’s stock in a transaction that occurred on Thursday, October 17th. The stock was sold at an average price of GBX 148 ($1.93), for a total transaction of £384,800 ($502,809.36). Also, insider Ben Dorks sold 650,000 shares of the company’s stock in a transaction that occurred on Monday, September 16th. The shares were sold at an average price of GBX 148 ($1.93), for a total value of £962,000 ($1,257,023.39).
Ideagen plc develops and supplies information management software in the United Kingdom, the United States, Bulgaria, Malaysia, and the Middle East. Its governance, risk and compliance (GRC) management solutions comprise Q-Pulse QMS, an electronic quality management system; Q-Pulse PM, a product management software; Pentana Audit, an audit automation application; Pentana Disclose, a financial disclosure checklist software; Pentana Performance, a cloud-based performance and risk management software; Coruson, an enterprise cloud safety management software; and PleaseReview, a document review, co-authoring, and redaction software.
Featured Article: Which market index is the best?
Receive News & Ratings for Ideagen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ideagen and related companies with MarketBeat.com's FREE daily email newsletter.